MEDS.O (MEDS.O) News
Follow MEDS.O (MEDS.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
DataMeds AI files draft information statement (Form PRE 14C)
DataMeds AI shareholders authorized an amendment to add 1,000,000 shares of blank-check preferred stock. Board gained flexibility to set terms for new preferred series, including voting, dividend, liquidation, conversion
REGULATION | Oct 13, 2026, 04:50 PM UTC
L
DataMeds AI plans ChemoFx marketing relaunch, targets gynecologic cancer diagnostic rollout
DataMeds AI will cut corporate management roles to redirect spending toward commercializing the ChemoFx diagnostic for gynecologic cancers. A marketing relaunch is being prepared, targeting oncologists to drive adoption
NEWS | Oct 13, 2026, 10:05 AM UTC